121 related articles for article (PubMed ID: 18693057)
1. [Use of PET for staging, treatment evaluation, and follow-up in esophageal cancers].
Touboul E; Huguet F; Talbot JN
Cancer Radiother; 2008 Nov; 12(6-7):633-9. PubMed ID: 18693057
[TBL] [Abstract][Full Text] [Related]
2. [Esophageal cancer].
Dupuis O; Ganem G; Béra G; Pointreau Y; Pradier O; Martin P; Mirabel X; Denis F
Cancer Radiother; 2010 Nov; 14 Suppl 1():S74-83. PubMed ID: 21129673
[TBL] [Abstract][Full Text] [Related]
3. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.
Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Houry S; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):340-5. PubMed ID: 16168829
[TBL] [Abstract][Full Text] [Related]
4. [Impact of computed tomography (CT) and 18F-deoxyglucose positron emission tomography (FDG-PET) image fusion for conformal radiotherapy in esophageal carcinoma].
Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petenief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Hourry S; Talbot JN
Cancer Radiother; 2005 May; 9(3):152-60. PubMed ID: 16023043
[TBL] [Abstract][Full Text] [Related]
5. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
[TBL] [Abstract][Full Text] [Related]
6. The role of PET in target localization for radiotherapy treatment planning.
Rembielak A; Price P
Onkologie; 2008 Feb; 31(1-2):57-62. PubMed ID: 18268401
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography in the staging of esophageal cancer.
Leccisotti L
Rays; 2006; 31(1):9-12. PubMed ID: 16999368
[TBL] [Abstract][Full Text] [Related]
8. ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography for Evaluating the Response to Neoadjuvant Chemotherapy in Advanced Esophageal Cancer.
Tani Y; Nakajima M; Kikuchi M; Ihara K; Muroi H; Takahashi M; Domeki Y; Okamoto K; Yamaguchi S; Sasaki K; Tsuchioka T; Sakamoto S; Kato H
Anticancer Res; 2016 Jan; 36(1):367-73. PubMed ID: 26722067
[TBL] [Abstract][Full Text] [Related]
9. Functional imaging for early prediction of response to chemoradiotherapy: 3'-deoxy-3'-18F-fluorothymidine positron emission tomography--a clinical application model of esophageal cancer.
Chao KS
Semin Oncol; 2006 Dec; 33(6 Suppl 11):S59-63. PubMed ID: 17178290
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET.
Westerterp M; Omloo JM; Sloof GW; Hulshof MC; Hoekstra OS; Crezee H; Boellaard R; Vervenne WL; ten Kate FJ; van Lanschot JJ
Int J Hyperthermia; 2006 Mar; 22(2):149-60. PubMed ID: 16754598
[TBL] [Abstract][Full Text] [Related]
11. Dose-related fluorodeoxyglucose uptake in acute radiation-induced hepatitis.
Nakahara T; Takagi Y; Takemasa K; Mitsui Y; Tsuyuki A; Shigematsu N; Kubo A
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1040-4. PubMed ID: 18787476
[TBL] [Abstract][Full Text] [Related]
12. Modern staging and utility of PET imaging in esophageal cancer management.
Chang KY; Chang JY; Chao J; Yen Y
J Natl Compr Canc Netw; 2008 Oct; 6(9):862-9. PubMed ID: 18926095
[TBL] [Abstract][Full Text] [Related]
13. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.
Levine EA; Farmer MR; Clark P; Mishra G; Ho C; Geisinger KR; Melin SA; Lovato J; Oaks T; Blackstock AW
Ann Surg; 2006 Apr; 243(4):472-8. PubMed ID: 16552197
[TBL] [Abstract][Full Text] [Related]
15. (18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.
zum Büschenfelde CM; Herrmann K; Schuster T; Geinitz H; Langer R; Becker K; Ott K; Ebert M; Zimmermann F; Friess H; Schwaiger M; Peschel C; Lordick F; Krause BJ
J Nucl Med; 2011 Aug; 52(8):1189-96. PubMed ID: 21764790
[TBL] [Abstract][Full Text] [Related]
16. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
Kauppi JT; Oksala N; Salo JA; Helin H; Karhumäki L; Kemppainen J; Sihvo EI; Räsänen JV
Acta Oncol; 2012 May; 51(5):636-44. PubMed ID: 22208782
[TBL] [Abstract][Full Text] [Related]
17. [The contribution of PET to radiation treatment planning].
Belkacémi Y; Lartigau E; Kerrou K; Carpentier P; Taïeb S; Giraud P
Bull Cancer; 2007 Jan; 94(1):99-108. PubMed ID: 17237010
[TBL] [Abstract][Full Text] [Related]
18. Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.
Kim MK; Ryu JS; Kim SB; Ahn JH; Kim SY; Park SI; Kim YH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
Eur J Cancer; 2007 Jun; 43(9):1385-91. PubMed ID: 17512192
[TBL] [Abstract][Full Text] [Related]
19. Reassessment of patients with esophageal cancer after neoadjuvant therapy.
Das A; Chak A
Endoscopy; 2006 Jun; 38 Suppl 1():S13-7. PubMed ID: 16802216
[No Abstract] [Full Text] [Related]
20. The importance of PET in the diagnosis and response evaluation of esophageal cancer.
Ott K; Weber W; Siewert JR
Dis Esophagus; 2006; 19(6):433-42. PubMed ID: 17069585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
